VPG

VPG is a quality precision-sensing business with a fortress balance sheet — $336M equity against $120M total liabilities (0.36x), $87.4M cash, only $20.6M long-term debt (down 34.5%), and a 4.5x current ratio — but the price has completely detached from the earnings reality. Revenue has gone nowhere ($307M, +0.2% YoY, and below the $363M FY2022 peak) while profitability has fallen off a cliff: net income has dropped four straight years from $36.1M (FY2022) to $5.29M (FY2025, -46.6%), diluted EPS is down to $0.40, net margin is 1.7%, and ROE is just 1.6%. At $142.09 the stock trades at 355x trailing EPS, 6.1x sales, and roughly 5.6x book — multiples that only make sense if you assume a sharp, durable earnings recovery that the filings do not support.

The MD&A and risk factors point the wrong way. Management took $1.5M of restructuring charges in 2025 and is 'evaluating plans to further reduce our costs by consolidating additional manufacturing operations' — a tell that demand is soft, not inflecting. Foreign exchange was a real 2025 headwind, adding only $2.8M to revenue but $7.4M to cost of sales and SG&A, a direct hit to already-thin margins. New U.S. tariffs from Q2 2025 plus reciprocal measures threaten a manufacturing footprint spread across India, China, Japan, Europe, Canada, Israel and the U.S., and the war in Israel adds geopolitical fragility to operations there. Notably, management leans heavily on a long list of non-GAAP 'adjusted' measures in the MD&A — usually a sign the GAAP picture is unflattering.